Clinical Trial

Role of the Immune System in Preventing Laryngeal Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation
Trial Details
NCT Number NCT07508319
Lead Sponsor European Institute of Oncology
Conditions Head & Neck Cancer
Enrollment 3 participants
Start Date 2025-11-19
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-02